CLINICAL_TRIALS
research
· 2026-04-24
Clinical Trial Update: Genetic Markers for Focal Segmental Glomerulosclerosis
Summary
This clinical trial update reports on genetic markers linked to focal segmental glomerulosclerosis, including HIV-associated forms. The study is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Focal Segmental Glomerulosclerosis, HIV-Associated Focal Segmental Glomerulosclerosis | Status: COMPLETED